高级检索
当前位置: 首页 > 详情页

Perceptions and Attitudes of Chinese Oncologists Toward Endorsing AI-Driven Chatbots for Health Information Seeking Among Patients with Cancer: Phenomenological Qualitative Study

文献详情

资源类型:
Pubmed体系:
机构: [1]Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. [2]Department of Gynecology and Obstetrics Nursing, West China Second University Hospital, Sichuan University, Chengdu, China. [3]West China School of Nursing, Sichuan University, Chengdu, China. [4]Key Laboratory of Birth Defects and Related Disease of Women and Children, Sichuan University, Chengdu, China. [5]Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China. [6]Department of Radiation Oncology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou, China
出处:
DOI: 10.2196/71418
ISSN:

关键词: artificial intelligence attitude chatbot health information seeking large language model liability misinformation oncologist perception patient education qualitative study

摘要:
Chatbots driven by large language model artificial intelligence (AI) have emerged as potential tools to enhance health information access for patients with cancer. However, their integration into patient education raises concerns among oncologists. Limited literature has examined the perceptions and attitudes of oncologists in terms of endorsing AI-driven chatbots for health information.This study aims to explore the perceptions and attitudes of Chinese oncologists toward endorsing AI-driven chatbots to patients with cancer.In this phenomenological qualitative study, we purposively sampled oncologists from 4 hospitals in Southwest and East China and conducted semistructured interviews with 24 participants between November 19, 2024, and December 21, 2024. The data saturation principle was observed to determine the end point of data collection. Data were analyzed using the Colaizzi method.The participants were aged 42.0 (range 29-53) years on average, including 9 (37%) female and 15 (62%) male participants. The participants had an average of 8.8 (range 1-25) years in oncology. Of the participants, 7 (29%) had recommended AI chatbots to patients. Three key themes were revealed from analysis of interview transcriptions, including perceived benefits, significant concerns, and impacts on doctor-patient dynamics. Benefits included enhanced accessibility and potential support for chronic condition management. Concerns centered on liability, misinformation, lack of personalization, privacy and data security risks, and patient readiness and education. Oncologists stressed a dual impact of AI chatbots on doctor-patient dynamics, recognizing the potential for improved communication and risks of trust erosion due to overreliance on AI.While recognizing the potential of AI-driven chatbots to enhance accessibility of health information and chronic disease management, Chinese oncologists report significant concerns, including liability, misinformation, lack of personalization, privacy and data security risks, and patient readiness. Addressing the challenges requires comprehensive solutions, such as clear policies and guidelines, rigorous testing and validation, institutional endorsement, and robust patient and provider education. Future efforts should focus on resolving the barriers while leveraging the strengths of AI technology to support patient-centered care in a safe, effective, and ethical manner.© Lijuan Zeng, Qiaoqi Li, Qiaoqi Li, Ying Zhang, Zhaojun Li. Originally published in the Journal of Medical Internet Research (https://www.jmir.org).

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务 2 区 医学:信息
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务 2 区 医学:信息
第一作者:
第一作者机构: [1]Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号